Fibromyalgia, Major Depressive Disorder, Generalized Anxiety Disorder, Panic Disorder, Social Phobia Mental and Behavioural Disorders
Conditions
Interventions
An online program, Research Randomized (http://www.randomizer.org/), will be used to generate a list of random numbers. Participants will be assigned to the treatment group using a 1:1 ratio using sim
n =30 waitlist control). To prevent selection bias, participant?s group assignment will be given by a graduate student, who is not involved in this study, to both the participant and study staff only
Sponsors
University of Regina (Canada)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Resident of Canada 2. Aged 18 years or older, either sex 3. Currently experiencing clinically significant symptoms of Fibromyalgia, depression, anxiety, social phobia, and/or panic 4. Has regular access to a computer, Internet, and printer 5. Comfortable using the Internet
Exclusion criteria
Exclusion criteria: 1. Not a resident of Canada 2. Less than 18 years of age 3. Has no regular access to a computer, Internet, and use of printer 4. Currently receiving psychotherapeutic treatment for pain, anxiety, or depression elsewhere or in some other form 5. Started a new psychotropic medication within the past month or had a change in dosage within the past month 6. Self-reported current problems with alcohol use or substance use 7. Self-reported current problems with psychotic disorder or bipolar disorder, or severe symptoms of depression, including frequent suicidal ideation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Revised Fibromyalgia Impact Questionnaire 2. Brief Pain Inventory 3. Patient Health Questionnaire- 9 Item 4. Generalized Anxiety Disorder ? 7 Item These will be administered at baseline, weekly, post-treatment, 1- and 3-month follow-up. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Hopital Anxiety and Depression Scale measured at baseline, post-treatment and at 3-month follow up 2. Pain Self-Efficacy Questionnaire measured at baseline, post-treatment and at 3-month follow up 3. Pain Responses Self-Statements at baseline, post-treatment 4. Visual Analogue Scale for Pain at baseline, weekly, post-treatment 5. Fatigue Symptom Inventory at baseline, post-treatment 6. TAMPA Scale of Kinesiophobia at baseline, post-treatment 7. Medical Outcomes Study Short Form at baseline, post-treatment and at 3-month follow up 8. Treatment Satisfaction Questionnaire measured post-treatment 9. Client Feedback Open-Ended Questions measured post-treatment | — |
Countries
Canada
Outcome results
None listed